News Tag: 2021 newsletters

Testing Durvalumab, Olaparib, and Cediranib in Women with Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer (NRG-GY023)

Read More

NRG Oncology Director of Administration, Meetings, and Exhibits, Denise Mackey, Retires After 38 Years

Read More

Outstanding NRG Oncology Researcher to Receive 2021 PA Breast Cancer Coalition Potamkin Prize

Read More

NRG Oncology Board of Directors Member, Dr. Jeff Michalski, Named ASTRO President-elect

Read More

Pathology and Biospecimen Tips for Success

Read More

Performance Status Measures – A Little History

Read More

Esophageal Cancer Awareness Month

Read More

Head and Neck Cancer Awareness Month

Read More

The Significance of Checkpoint Inhibitors and MMR/MSI Testing in Metastatic Colorectal Cancer (NRG-GI004/SWOG1610, the COMMIT Study)

Read More